Adapting a prescreening program to match molecular alterations in over 5,000 patients’ tumors with targeted agents and immunotherapies in early clinical trials over the last 8 years

S. Aguilar; A. Vivancos; P. Nuciforo; C. Viaplana; F. Ruiz-Pace; E. Sanchez; J. Rodon; J. Tabernero; E. Garralda; R. Dienstmann

doi:10.1093/annonc/mdy314.007

Adapting a prescreening program to match molecular alterations in over 5,000 patients’ tumors with targeted agents and immunotherapies in early clinical trials over the last 8 years

S. Aguilar, A. Vivancos, P. Nuciforo, C. Viaplana, F. Ruiz-Pace, E. Sanchez, J. Rodon, J. Tabernero, E. Garralda, R. Dienstmann

Investigational Cancer Therapeutics

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	vi23
Journal	Annals of Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy314.007
State	Published - Sep 2018

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdy314.007

Cite this

Aguilar, S., Vivancos, A., Nuciforo, P., Viaplana, C., Ruiz-Pace, F., Sanchez, E., Rodon, J., Tabernero, J., Garralda, E., & Dienstmann, R. (2018). Adapting a prescreening program to match molecular alterations in over 5,000 patients’ tumors with targeted agents and immunotherapies in early clinical trials over the last 8 years. Annals of Oncology, 29, vi23. https://doi.org/10.1093/annonc/mdy314.007

Aguilar, S, Vivancos, A, Nuciforo, P, Viaplana, C, Ruiz-Pace, F, Sanchez, E, Rodon, J, Tabernero, J, Garralda, E & Dienstmann, R 2018, 'Adapting a prescreening program to match molecular alterations in over 5,000 patients’ tumors with targeted agents and immunotherapies in early clinical trials over the last 8 years', Annals of Oncology, vol. 29, pp. vi23. https://doi.org/10.1093/annonc/mdy314.007

@article{14ff87ecdfee4aabb0079fdb7c90b2c1,

title = "Adapting a prescreening program to match molecular alterations in over 5,000 patients{\textquoteright} tumors with targeted agents and immunotherapies in early clinical trials over the last 8 years",

author = "S. Aguilar and A. Vivancos and P. Nuciforo and C. Viaplana and F. Ruiz-Pace and E. Sanchez and J. Rodon and J. Tabernero and E. Garralda and R. Dienstmann",

year = "2018",

month = sep,

doi = "10.1093/annonc/mdy314.007",

language = "English (US)",

volume = "29",

pages = "vi23",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Adapting a prescreening program to match molecular alterations in over 5,000 patients’ tumors with targeted agents and immunotherapies in early clinical trials over the last 8 years

AU - Aguilar, S.

AU - Vivancos, A.

AU - Nuciforo, P.

AU - Viaplana, C.

AU - Ruiz-Pace, F.

AU - Sanchez, E.

AU - Rodon, J.

AU - Tabernero, J.

AU - Garralda, E.

AU - Dienstmann, R.

PY - 2018/9

Y1 - 2018/9

UR - http://www.scopus.com/inward/record.url?scp=85081534917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081534917&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy314.007

DO - 10.1093/annonc/mdy314.007

M3 - Article

C2 - 32177620

SN - 0923-7534

VL - 29

SP - vi23

JO - Annals of Oncology

JF - Annals of Oncology

ER -

Adapting a prescreening program to match molecular alterations in over 5,000 patients’ tumors with targeted agents and immunotherapies in early clinical trials over the last 8 years

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this